What to Do Now: A Prioritised Action Plan
Following the March 2026 revision, CCOs at mid-market financial institutions should act on the following in priority order:
- map your current compliance programme against the new consolidated mandatory baseline. Document each gap, its regulatory basis, its risk implication, and a remediation target date. This assessment is the prerequisite for everything else. Gap assessment (immediate)
- assess whether your transaction monitoring and STR management infrastructure can generate evidence of the quality the revised guidelines require. If not, this is a regulatory risk management decision, not a technology investment decision. Technology review (within 90 days)
- review management information structures and board reporting to ensure they reflect the FSA’s new governance expectations. Update board reporting content and frequency if required. Governance documentation (within 90 days)
- where compliance functions are outsourced or run through group infrastructure, document the oversight arrangements explicitly. This documentation must be available to FSA examiners. Outsourcing documentation (within 60 days)
- treat the March 2026 revision as the reference framework for your 2028 FATF preparation. The revised guidelines represent the FSA’s current expectations and are the standard against which the 2028 on-site examination will assess effectiveness. FATF 2028 alignment (ongoing)
The Connection to the 2028 FATF Evaluation
The timing of the March 2026 revision is not coincidental. Japan’s 5th Round Mutual Evaluation on-site inspection is scheduled for August 2028. The FSA is ensuring that Japan’s domestic compliance standards fully reflect FATF Recommendations before international examiners arrive to assess effectiveness.
For CCOs at mid-market institutions, this creates a specific and time-limited preparation window. Institutions that begin their gap remediation programme now — with appropriate technology infrastructure in place by mid-2027 — will have 12 to 18 months of operational performance data to demonstrate effectiveness before the examination cycle begins. Institutions that delay until 2027 will not have that operational history.
The evidence base for effectiveness assessment is built over time. It cannot be retrospectively created. The preparation window that exists now is the one that matters.
Frequently Asked Questions
Japan FSA AML/CFT Guidelines 2026: What Changed | Nexiant
The March 2026 FSA revision collapsed Japan’s three-tier AML framework into one mandatory baseline. Learn what changed, who is most affected, and what actions are required.
Speak to our teamThis article was accurate at the time of publication in June 2026 and is intended for general informational purposes only. It does not constitute legal, regulatory or compliance advice. Organisations should seek qualified professional guidance in relation to their specific obligations.




